Moustafa Abdou/LinkedIn
Aug 4, 2026, 14:43
Moustafa Abdou: How to Recognize and Manage Hematologic Emergencies in Time
Moustafa Abdou, Author and Founder of AskHematologist.com, shared a post on LinkedIn:
“Rapid cell lysis. Microvascular sludging. Silent consumptive coagulopathy. In acute oncology and hematology, a stable patient can head downhill in a matter of hours.
Having a clear, practical diagnostic approach on hand makes all the difference when you’re on call.
I updated my full clinical reference guide on Hematologic Emergencies, walking step-by-step through the recognition, laboratory workups, and emergency management of:
- Hyperviscosity Syndrome and Fundoscopic Pearls
- Hypercalcemia of Malignancy (PTHrP vs. Osteolytic pathways)
- Sickle Cell Crises (Vaso-occlusive through to Acute Chest Syndrome)
- Tumor Lysis Syndrome (Rasburicase vs. Allopurinol timing)
- DIC and Neutropenic Sepsis (Consumptive coagulopathy and empiric protocols)
Designed as a practical refresher for hematologists, oncologists, internists, and emergency care teams.
Read the complete article here.”

Other posts featuring Moustafa Abdou on Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden